Trans India House Impex Limited announced its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The Board of Directors approved the results at their meeting held on February 12, 2026, following review by the Audit Committee and limited review by statutory auditors Manoj Acharya & Associates.

Standalone Financial Performance

The company's standalone operations showed mixed results for Q3 FY26. Revenue from operations declined significantly to ₹356.74 lakhs compared to ₹1,531.56 lakhs in Q3 FY25, representing a substantial year-over-year decrease.

For the nine-month period ended December 31, 2025, revenue from operations increased to ₹3,843.07 lakhs from ₹3,264.29 lakhs in the corresponding period of FY25. However, net profit declined significantly to ₹9.67 lakhs from ₹101.23 lakhs in the previous year.

Consolidated Results

The consolidated financial results, which include subsidiary TIHIL IDA Group Private Limited, showed better performance in Q3 FY26. Consolidated revenue from operations was ₹654.88 lakhs compared to ₹1,531.56 lakhs in Q3 FY25.

Operational Highlights

The company operates primarily in the trading of goods segment. Total expenses for standalone operations in Q3 FY26 were ₹41.40 lakhs compared to ₹91.00 lakhs in Q3 FY25. Key expense components included employee benefit expenses of ₹13.69 lakhs, finance costs of ₹36.37 lakhs, and depreciation of ₹2.69 lakhs.

Auditor's Observations

The statutory auditors noted that the company is in the process of obtaining balance confirmations from certain trade debtors. Several confirmations remain pending, and the auditors were unable to satisfy themselves regarding the recoverability and accuracy of such outstanding balances. Management indicated that provisions for doubtful debts may be required at year-end, which could impact profitability.

Corporate Information

The company's paid-up equity share capital stands at ₹7,105.20 lakhs with a face value of ₹10 per share. The results were signed by Chairman and Whole-Time Director Mayank Suresh Jolly. The financial statements were prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under the Companies Act, 2013.

Trans india house impex Limited has scheduled a board meeting for February 12, 2026, to review and approve its third quarter financial performance for FY26. The company formally notified BSE Limited about the upcoming board meeting through an official communication dated February 3, 2026.

Board Meeting Agenda

The board meeting will focus on two primary matters requiring directors' consideration and approval:

Regulatory Compliance Framework

The board meeting has been scheduled in accordance with multiple SEBI regulations to ensure full regulatory compliance. The company is adhering to Regulation 29(1) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with other applicable regulations as amended from time to time.

Trading Window Restrictions

Trans India House Impex Limited has implemented comprehensive trading window restrictions for designated persons as part of its insider trading prevention measures. The trading window closure details are structured as follows:

The trading window restrictions demonstrate the company's commitment to maintaining transparency and preventing any potential insider trading activities during the financial results preparation and announcement period.

Company Information

Trans India House Impex Limited operates under CIN L74110GJ1987PLC152434 and trades on BSE with scrip code 523752. The company's registered office is located in Ahmedabad, Gujarat, and it maintains regular communication with stakeholders through its compliance framework managed by Company Secretary and Compliance Officer Mrugesh Ashwin Kumar Vyas.